Type 1 Diabetes Research Funding
The Type 1 Diabetes Grand Challenge, supported by the Steve Morgan Foundation, Diabetes UK, and JDRF, announced £2.7 million in funding for six global research projects. These initiatives, launched on August 12, 2024, focus on developing advanced insulin therapies that mimic the pancreas’s natural function, improving blood sugar control. Key research includes creating Glucose Responsive Insulins (GRIs), ultrafast insulins, and combining insulin with glucagon therapy. Researchers from institutions in Australia, the U.S., and China aim to address challenges in current insulin treatments, providing hope for better diabetes management.
If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.
